SomnoMed Limited SOM.AX · Stock Open SomnoMed Limited in new tab
SomnoMed Limited Analysis (SOM.AX)
Is SomnoMed Limited a good investment? SomnoMed Limited (SOM.AX) is currently trading at 0.3400 AUD. Market analysts have a consensus price target of 0.84 AUD. This suggests a potential upside from current levels.
Earnings Schedule: SomnoMed Limited is expected to release its next earnings report on Feb. 26, 2027. The market consensus estimate for Forward EPS is 0.02.
Investor FAQ
Does SomnoMed Limited pay a dividend?
No, it does not currently pay a dividend.
What asset class is SomnoMed Limited?
SomnoMed Limited is classified as a Stock. You can compare it against 3 other assets in the "Related Symbols" list on this page.
When is the next earnings date?
The next earnings date is projected to be Feb. 26, 2027. The company currently has a trailing EPS of -0.01.
Company Profile
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. The company offers SomnoDent, such as SomnoDent Avant, SomnoDent Classic, SomnoDent Flex, herbst advance, and SomnoDent Fusion for the treatment of obstructive sleep apnea. It also provides SomMorning Repositioner, a product designed to help return patient's mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient's upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs, which are cleaning tablets to clean oral appliances. SomnoMed Limited was incorporated in 1987 and is headquartered in Crows Nest, Australia.
| Split Date | Split Ratio to 1 |
|---|---|
| Nov. 16, 2006 | 2.03 |
| Nov. 27, 2009 | 1:20 |
| March 26, 2020 | 1.16 |
| Sept. 4, 2023 | 1.04 |
Community Discussion